Cargando…
No Dopamine Cell Loss or Changes in Cytoskeleton Function in Transgenic Mice Expressing Physiological Levels of Wild Type or G2019S Mutant LRRK2 and in Human Fibroblasts
Mutations within the LRRK2 gene have been identified in Parkinson’s disease (PD) patients and have been implicated in the dysfunction of several cellular pathways. Here, we explore how pathogenic mutations and the inhibition of LRRK2 kinase activity affect cytoskeleton dynamics in mouse and human ce...
Autores principales: | Garcia-Miralles, Marta, Coomaraswamy, Janaky, Häbig, Karina, Herzig, Martin C., Funk, Natalja, Gillardon, Frank, Maisel, Martina, Jucker, Mathias, Gasser, Thomas, Galter, Dagmar, Biskup, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382199/ https://www.ncbi.nlm.nih.gov/pubmed/25830304 http://dx.doi.org/10.1371/journal.pone.0118947 |
Ejemplares similares
-
The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4
por: Funk, Natalja, et al.
Publicado: (2019) -
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
por: Biskup, Saskia, et al.
Publicado: (2007) -
ARHGEF7 (BETA-PIX) Acts as Guanine Nucleotide Exchange Factor for Leucine-Rich Repeat Kinase 2
por: Haebig, Karina, et al.
Publicado: (2010) -
Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity
por: Zach, Susanne, et al.
Publicado: (2010) -
Role of LRRK2 in the regulation of dopamine receptor trafficking
por: Rassu, Mauro, et al.
Publicado: (2017)